Platinum Equity completed the acquisition of a majority stake in OSD business of Inventia Healthcare from a consortium of investors.

Platinum Equity, a private equity firm, completed the acquisition of a majority stake in OSD business of Inventia Healthcare, a pharmaceutical company, from a consortium of investors including India Life Sciences Fund, NYLIM Jacob Ballas India Fund and Shah family. Financial terms were not disclosed. "We believe Inventia is a strong platform for growth in a fragmented market, and our goal is to create a larger, more diversified B2B business focused on the attractive but underserved emerging markets. We are excited to build upon the strong foundation set by the Shah family by bringing in our operational and financial resources to further institutionalize the company and set it up for success on a significantly greater scale. Inventia's current product pipeline can drive strong organic growth over the foreseeable future, which we will look to enhance through acquisitions, with an emphasis on broadening the company's product portfolio and capabilities," Amit Sobti, Platinum Equity Managing Director.